Cargando…
Exogenous Glucose–Dependent Insulinotropic Polypeptide Worsens Post prandial Hyperglycemia in T ype 2 Diabetes
OBJECTIVE: Glucose-dependent insulinotropic polypeptide (GIP), unlike glucagon-like peptide (GLP)-1, lacks glucose-lowering properties in patients with type 2 diabetes. We designed this study to elucidate the underlying pathophysiology. RESEARCH DESIGN AND METHODS: Twenty-two insulin-naïve subjects...
Autores principales: | Chia, Chee W., Carlson, Olga D., Kim, Wook, Shin, Yu-Kyong, Charles, Cornelia P., Kim, Hee Seung, Melvin, Denise L., Egan, Josephine M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682676/ https://www.ncbi.nlm.nih.gov/pubmed/19276444 http://dx.doi.org/10.2337/db08-0958 |
Ejemplares similares
-
Post-prandial hyperglycemia
por: Singh, Santosh Kumar
Publicado: (2012) -
The Effect of Exogenous Glucose-Dependent Insulinotropic Polypeptide in Combination With Glucagon-Like Peptide-1 on Glycemia in the Critically Ill
por: Lee, Michael Y., et al.
Publicado: (2013) -
Gastric inhibitory polypeptide/glucose‐dependent insulinotropic polypeptide signaling in adipose tissue
por: Yamane, Shunsuke, et al.
Publicado: (2018) -
Searching for the physiological role of glucose‐dependent insulinotropic polypeptide
por: Holst, Jens Juul, et al.
Publicado: (2016) -
Glucose‐dependent insulinotropic polypeptide signaling in pancreatic β‐cells and adipocytes
por: McIntosh, Christopher HS, et al.
Publicado: (2012)